NO20061441L - Nye tiotropiumsalter, metoder for deres fremstilling, og farmasoytiske formuleringer inneholdende disse - Google Patents

Nye tiotropiumsalter, metoder for deres fremstilling, og farmasoytiske formuleringer inneholdende disse

Info

Publication number: NO20061441L
Authority: NO; Norway
Prior art keywords: preparation; methods; formulations containing; pharmaceutical formulations; tiotropium salts
Prior art date: 2003-11-03

Application number

NO20061441A

Other languages

English (en)

Norwegian (no)

Inventor

Rolf Banholzer

Waldemar Pfrengle

Peter Sieger

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-03

Filing date

2006-03-30

Publication date

2006-07-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34530661&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20061441(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-03-30 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2006-07-12 Publication of NO20061441L publication Critical patent/NO20061441L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pulmonology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20061441A 2003-11-03 2006-03-30 Nye tiotropiumsalter, metoder for deres fremstilling, og farmasoytiske formuleringer inneholdende disse NO20061441L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03025076		2003-11-03
PCT/EP2004/012270 WO2005042528A1 (fr)	2003-11-03	2004-10-29	Nouveaux sels de tiotropium, procedes permettant de les produire et formulations medicamenteuses les contenant

Publications (1)

Publication Number	Publication Date
NO20061441L true NO20061441L (no)	2006-07-12

Family

ID=34530661

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20061441A NO20061441L (no)	2003-11-03	2006-03-30	Nye tiotropiumsalter, metoder for deres fremstilling, og farmasoytiske formuleringer inneholdende disse

Country Status (28)

Country	Link
US (1)	US20050096341A1 (fr)
EP (5)	EP2083007B1 (fr)
JP (1)	JP5165245B2 (fr)
KR (1)	KR20060102561A (fr)
CN (3)	CN1875020B (fr)
AR (1)	AR046318A1 (fr)
AT (1)	ATE478071T1 (fr)
AU (1)	AU2004285685B2 (fr)
CA (1)	CA2544357A1 (fr)
CO (1)	CO5690554A2 (fr)
DE (1)	DE502004011562D1 (fr)
DK (2)	DK2083007T3 (fr)
EA (1)	EA012369B1 (fr)
EC (2)	ECSP066544A (fr)
ES (2)	ES2422730T3 (fr)
IL (1)	IL175127A (fr)
MY (1)	MY145166A (fr)
NO (1)	NO20061441L (fr)
NZ (1)	NZ547523A (fr)
PE (1)	PE20050485A1 (fr)
PL (1)	PL2083007T3 (fr)
RS (1)	RS20060293A (fr)
SG (1)	SG149876A1 (fr)
TW (1)	TW200523263A (fr)
UA (1)	UA82414C2 (fr)
UY (1)	UY28589A1 (fr)
WO (1)	WO2005042528A1 (fr)
ZA (1)	ZA200602343B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2342468T3 (es) *	2003-11-03	2010-07-07	Boehringer Ingelheim International Gmbh	Procedimiento para la preparacion de sales de tiotropio.
MX2007015997A (es) *	2005-06-15	2008-03-07	Boehringer Ingelheim Int	Procedimiento para preparar nuevas sales de tiotropio, nuevas sales de tiotropio como tales y composiciones farmaceuticas de las mismas.
EP1898894A1 (fr) *	2005-06-17	2008-03-19	Boehringer Ingelheim International GmbH	Inhibiteurs mrp iv pour le traitement de maladies respiratoires
DE102005035112A1 (de) *	2005-07-27	2007-02-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
US9108962B2 (en)	2005-12-19	2015-08-18	Sicor, Inc.	Forms of tiotropium bromide and processes for preparation thereof
US20070167480A1 (en) *	2005-12-19	2007-07-19	Sicor Inc.	Pure and stable tiotropium bromide
CN102731494A (zh) *	2005-12-19	2012-10-17	西科尔公司	噻托溴铵的新形式及其制备方法
WO2007075838A2 (fr) *	2005-12-19	2007-07-05	Sicor Inc.	Bromure de tiotropium pur et stable
US20080051582A1 (en) *	2006-07-10	2008-02-28	Sicor Inc.	Process for the preparation of tiotropium bromide
EP1925295A1 (fr) *	2006-11-22	2008-05-28	Boehringer Ingelheim Pharma GmbH & Co. KG	Formule de poudre stable contenant un nouveau anticholinergique
WO2008089852A1 (fr) *	2007-01-26	2008-07-31	Boehringer Ingelheim Pharma Gmbh & Co.Kg	Nouveau procédé de préparation de sels de tiotropium
EP1953156A1 (fr) *	2007-01-29	2008-08-06	Boehringer Ingelheim Pharma GmbH & Co. KG	Procédé de fabrication de sels de scopinium
WO2010110760A1 (fr) *	2009-03-27	2010-09-30	Mahmut Bilgic	Compositions comprenant de l'eau et du deutérium destinées à prévenir ou à traiter des maladies allergiques et procédé de préparation de celles-ci
PL388070A1 (pl) *	2009-05-19	2010-11-22	Adamed Spółka Z Ograniczoną Odpowiedzialnością	Nowe sole tiotropium
CZ201241A3 (cs) *	2012-01-20	2013-07-31	Zentiva, K.S.	Nové polymorfní formy tiotropium jodidu a zpusob jejich prípravy
JP6335798B2 (ja) *	2012-02-28	2018-05-30	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規噴射剤含有チオトロピウム製剤

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2597329A (en) *	1947-08-06	1952-05-20	Merck & Co Inc	Process for anion exchange of thiamin salts
US3551492A (en) *	1967-10-31	1970-12-29	Ciba Geigy Corp	N,n'-diaminoalkoxy-benzyl-diamino-alkanes and the salts thereof
US4570630A (en)	1983-08-03	1986-02-18	Miles Laboratories, Inc.	Medicament inhalation device
FR2585563B1 (fr)	1985-07-30	1993-11-12	Glaxo Group Ltd	Dispositif pour administrer des medicaments a des patients
US5610163A (en) *	1989-09-16	1997-03-11	Boehringer Ingelheim Gmbh	Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) *	1989-09-16	2000-04-06	Boehringer Ingelheim Kg	Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE4318455A1 (de)	1993-06-03	1994-12-08	Boehringer Ingelheim Kg	Kapselhalterung
DE19536902A1 (de)	1995-10-04	1997-04-10	Boehringer Ingelheim Int	Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
JP4023086B2 (ja) *	1999-12-27	2007-12-19	和光純薬工業株式会社	スルホニウム塩化合物
UA75375C2 (en)	2000-10-12	2006-04-17	Boehringer Ingelheim Pharma	Method for producing powdery preparations for inhaling
IL155335A0 (en) *	2000-10-12	2003-11-23	Boehringer Ingelheim Pharma	Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
EP1430887A1 (fr)	2000-10-12	2004-06-23	Boehringer Ingelheim Pharma GmbH & Co.KG	Poudre pour inhalation contenant du tiotropium
US6908928B2 (en) *	2000-10-12	2005-06-21	Bi Pharma Kg.	Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US20020111363A1 (en) *	2000-10-31	2002-08-15	Karin Drechsel	Inhalable formulation of a solution containing a tiotropium salt
US20020137764A1 (en) *	2000-10-31	2002-09-26	Karin Drechsel	Inhalable formulation of a solution containing a tiotropium salt
US20020183292A1 (en) *	2000-10-31	2002-12-05	Michel Pairet	Pharmaceutical compositions based on anticholinergics and corticosteroids
US20020193393A1 (en) *	2001-03-07	2002-12-19	Michel Pairet	Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
IL155538A0 (en) *	2000-10-31	2003-11-23	Boehringer Ingelheim Pharma	Inhalative solution formulation containing a tiotropium salt
US20020193392A1 (en) *	2000-11-13	2002-12-19	Christel Schmelzer	Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
DE10056104A1 (de) *	2000-11-13	2002-05-23	Boehringer Ingelheim Pharma	Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
DE10061877A1 (de) *	2000-12-12	2002-06-13	Basf Ag	Verfahren zur Herstellung wässriger Copolymerisatdispersionen von Copolymerisaten aus Kohlenmonoxid und wenigstens einer olefinisch ungesättigten Verbindung
DE10064816A1 (de) *	2000-12-22	2002-06-27	Boehringer Ingelheim Pharma	Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) *	2001-01-31	2003-01-14	Boehringer Ingelheim Pharma Ag	Process for preparing a scopine ester intermediate
US20020193394A1 (en) *	2001-03-13	2002-12-19	Bernd Disse	Compounds for treating inflammatory diseases
DE10111843A1 (de) *	2001-03-13	2002-09-19	Boehringer Ingelheim Pharma	Verbindungen zur Behandlung von inflammatorischen Erkrankungen
US20030070679A1 (en) *	2001-06-01	2003-04-17	Boehringer Ingelheim Pharma Kg	Capsules containing inhalable tiotropium
US6608055B2 (en) *	2001-06-22	2003-08-19	Boehringer Ingelheim Pharma Kg	Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6919325B2 (en) *	2001-09-14	2005-07-19	Boehringer Ingelheim Pharma Kg	Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
DE10200943A1 (de) *	2002-01-12	2003-07-24	Boehringer Ingelheim Pharma	Verfahren zur Herstellung von Scopinestern
US20030229227A1 (en) *	2002-03-16	2003-12-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	New difurylglycolic acid esters, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions
DE10212264A1 (de)	2002-03-20	2003-10-02	Boehringer Ingelheim Pharma	Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US20030235538A1 (en) *	2002-04-09	2003-12-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Method for the administration of an anticholinergic by inhalation
US6908055B2 (en) *	2003-02-27	2005-06-21	Tandberg Data Asa	System for extracting magnetic recording tape from a tape cartridge for engagement with a take-up reel
US20050030040A1 (en) *	2003-06-27	2005-02-10	Mitch Budniak	Electrical testing device having voice annunciator
US7968717B2 (en) *	2003-11-03	2011-06-28	Boehringer Ingelhein International Gmbh	Crystalline anhydrate with anticholinergic efficacy
ES2342468T3 (es) *	2003-11-03	2010-07-07	Boehringer Ingelheim International Gmbh	Procedimiento para la preparacion de sales de tiotropio.
SE0303270L (sv) *	2003-12-03	2005-06-04	Microdrug Ag	Metod för administration av tiotropium
SE0303570L (sv) *	2003-12-03	2005-06-04	Microdrug Ag	Fukt-känslig medicinsk produkt
DE102004041253A1 (de) *	2004-08-26	2006-03-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neues Verfahren zur Herstellung von Tiotropiumsalzen
MX2007015997A (es) *	2005-06-15	2008-03-07	Boehringer Ingelheim Int	Procedimiento para preparar nuevas sales de tiotropio, nuevas sales de tiotropio como tales y composiciones farmaceuticas de las mismas.

2004
- 2004-10-29 UA UAA200605765A patent/UA82414C2/uk unknown
- 2004-10-29 KR KR1020067010833A patent/KR20060102561A/ko not_active Ceased
- 2004-10-29 EP EP09157299.0A patent/EP2083007B1/fr not_active Expired - Lifetime
- 2004-10-29 PL PL09157299T patent/PL2083007T3/pl unknown
- 2004-10-29 JP JP2006537209A patent/JP5165245B2/ja not_active Expired - Lifetime
- 2004-10-29 EA EA200600854A patent/EA012369B1/ru not_active IP Right Cessation
- 2004-10-29 EP EP04791030A patent/EP1682543B1/fr not_active Expired - Lifetime
- 2004-10-29 EP EP10180198A patent/EP2319844A1/fr not_active Withdrawn
- 2004-10-29 DK DK09157299.0T patent/DK2083007T3/da active
- 2004-10-29 ES ES09157299T patent/ES2422730T3/es not_active Expired - Lifetime
- 2004-10-29 RS YUP-2006/0293A patent/RS20060293A/sr unknown
- 2004-10-29 EP EP10180177A patent/EP2322522A1/fr not_active Withdrawn
- 2004-10-29 CN CN2004800325224A patent/CN1875020B/zh not_active Expired - Lifetime
- 2004-10-29 EP EP10180191A patent/EP2336127A1/fr not_active Withdrawn
- 2004-10-29 WO PCT/EP2004/012270 patent/WO2005042528A1/fr not_active Ceased
- 2004-10-29 PE PE2004001046A patent/PE20050485A1/es not_active IP Right Cessation
- 2004-10-29 CN CN200910165195.4A patent/CN101648950B/zh not_active Expired - Lifetime
- 2004-10-29 DE DE502004011562T patent/DE502004011562D1/de not_active Expired - Lifetime
- 2004-10-29 CA CA002544357A patent/CA2544357A1/fr not_active Abandoned
- 2004-10-29 AT AT04791030T patent/ATE478071T1/de active
- 2004-10-29 UY UY28589A patent/UY28589A1/es not_active Application Discontinuation
- 2004-10-29 SG SG200900492-0A patent/SG149876A1/en unknown
- 2004-10-29 DK DK04791030.2T patent/DK1682543T3/da active
- 2004-10-29 AU AU2004285685A patent/AU2004285685B2/en not_active Expired
- 2004-10-29 ES ES04791030T patent/ES2350981T3/es not_active Expired - Lifetime
- 2004-10-29 NZ NZ547523A patent/NZ547523A/xx not_active IP Right Cessation
- 2004-10-29 CN CN201210447516.1A patent/CN102964344B/zh not_active Expired - Lifetime
- 2004-10-29 US US10/976,688 patent/US20050096341A1/en not_active Abandoned
- 2004-11-01 MY MYPI20044523A patent/MY145166A/en unknown
- 2004-11-02 TW TW093133400A patent/TW200523263A/zh unknown
- 2004-11-03 AR ARP040104039A patent/AR046318A1/es not_active Application Discontinuation
2006
- 2006-03-22 ZA ZA200602343A patent/ZA200602343B/en unknown
- 2006-03-30 NO NO20061441A patent/NO20061441L/no not_active Application Discontinuation
- 2006-04-24 IL IL175127A patent/IL175127A/en active IP Right Grant
- 2006-05-02 CO CO06041175A patent/CO5690554A2/es not_active Application Discontinuation
- 2006-05-03 EC EC2006006544A patent/ECSP066544A/es unknown
- 2006-05-03 EC EC2006006545A patent/ECSP066545A/es unknown

Also Published As

Publication number	Publication date
UY28589A1 (es)	2005-06-30
CN1875020A (zh)	2006-12-06
DK2083007T3 (da)	2013-07-29
RS20060293A (sr)	2008-08-07
UA82414C2 (uk)	2008-04-10
EA200600854A1 (ru)	2006-10-27
EP2083007A1 (fr)	2009-07-29
ECSP066545A (es)	2006-10-17
US20050096341A1 (en)	2005-05-05
ES2350981T3 (es)	2011-01-28
CN101648950B (zh)	2014-05-07
HK1099753A1 (zh)	2007-08-24
JP5165245B2 (ja)	2013-03-21
IL175127A (en)	2011-10-31
IL175127A0 (en)	2006-09-05
EP2322522A1 (fr)	2011-05-18
ECSP066544A (es)	2006-10-17
ZA200602343B (en)	2007-12-27
EP2336127A1 (fr)	2011-06-22
EA012369B1 (ru)	2009-10-30
KR20060102561A (ko)	2006-09-27
DK1682543T3 (da)	2010-12-13
CN1875020B (zh)	2010-04-28
CO5690554A2 (es)	2006-10-31
AU2004285685A1 (en)	2005-05-12
ATE478071T1 (de)	2010-09-15
CN101648950A (zh)	2010-02-17
WO2005042528A1 (fr)	2005-05-12
CA2544357A1 (fr)	2005-05-12
EP1682543B1 (fr)	2010-08-18
NZ547523A (en)	2009-07-31
ES2422730T3 (es)	2013-09-13
EP1682543A1 (fr)	2006-07-26
JP2007509895A (ja)	2007-04-19
DE502004011562D1 (de)	2010-09-30
EP2083007B1 (fr)	2013-04-24
MY145166A (en)	2011-12-30
SG149876A1 (en)	2009-02-27
TW200523263A (en)	2005-07-16
PL2083007T3 (pl)	2013-09-30
PE20050485A1 (es)	2005-10-05
EP2319844A1 (fr)	2011-05-11
CN102964344A (zh)	2013-03-13
AU2004285685B2 (en)	2011-03-24
CN102964344B (zh)	2014-12-31
AR046318A1 (es)	2005-11-30

Publication	Publication Date	Title
NO20061441L (no)	2006-07-12	Nye tiotropiumsalter, metoder for deres fremstilling, og farmasoytiske formuleringer inneholdende disse
NO20053548L (no)	2005-09-02	Pulvermedikament for inhalering inneholdende et tiotropiumsalt og salmeterolxinafoat.
CY1114157T1 (el)	2016-08-31	Αλατα του τιοτροπιου, μεθοδος για την παραγωγη τους και φαρμακευτικα σκευασματα που τα περιεχουν
MEP30108A (en)	2010-06-10	Formoterol superfine formulation
ATE330589T1 (de)	2006-07-15	Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege
ECSP024268A (es)	2002-08-01	Nuevos polvos para inhalacion que contienen tiotropio
NO20025221D0 (no)	2002-10-31	Nytt preparat
NO20062569L (no)	2006-07-12	Nye krystallinske anhydrider med antikolinergisk effekt
EA201201397A1 (ru)	2013-05-30	Ингалятор, содержащий расслаиваемую блистерную упаковку
NO20044107L (no)	2004-11-04	Medikamenter inneholdende betamimetica og et nytt anticholinergisk legemiddel
NO20081480L (no)	2008-05-16	Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma
NO20051956L (no)	2005-07-22	Salmeterol superfin formulering
CY1108420T1 (el)	2014-04-09	Προτοτυπο τιοτροπιουχο κονιωδες σκευασμα για εισπνοη
NO20073909L (no)	2007-10-24	Forstover-formulering
BR0308984A (pt)	2005-02-09	Formulações em pó adequadas para inalação
CY1113392T1 (el)	2016-06-22	Νεες κρυσταλλικες μορφες του βρωμιουχου τιοτροπιου
WO2005007134A8 (fr)	2006-06-15	Compositions pulverulentes pour l'inhalation, contenant un nouvel agent anticholinergique
BRPI0415685A (pt)	2006-12-26	sais de tiotrópio, processos para sua produção, bem como formulações de medicamentos contendo os mesmos

Legal Events

Date	Code	Title	Description
2011-05-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application